In view of the plans made by national health authorities in every country across the world for the widespread vaccination of individuals against the SARS-CoV-2 virus, the Thalassaemia International Federation herein presents the latest information concerning the to-date authorized vaccinations, as well as the Federation’s position about the vaccination of patients with haemoglobin disorders against SARS-CoV-2.
مقالات ذات صلة
Hemanext® Inc. Receives CE Mark Certification For Innovative Red Blood Cell (RBC) Processing & Storage System
The future of genome editing in Europe – Bringing together the views of government, industry, patient communities, and civil society’ representatives
أكتوبر 7, 2019
يونيو 30, 2020